pharmacopsychiatry
130595
DE
EN
Home
Products
Journals
Books
Book Series
Service
Library Service
Help
Contact
Portal
Pharmacopsychiatry
Full-text search
Full-text search
Author Search
Title Search
DOI Search
Metadata Search
Journal
About
Editorial Board
German National License
Imprint
X
Authors
Information for Authors
Submit a Manuscript
Subscription
Subscription Information & Contacts
Institutional Licencing
AGNP
Official Journal of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie
Collections
Pharmacopsychiatry Women
About Women in Medicine
Open Access
Not Logged In
Login
Username or e-mail address:
Password:
Forgot Access Data?
Register Now
OpenAthens/Shibboleth Login
Shopping Cart
Year (Archive)
2024
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
1980
1979
1978
1977
1976
1975
1974
1973
1972
1971
1970
1969
1968
Issues
Current Issue
Free Sample Issue (01/2024)
Related Journals
Drug Research
Planta Medica
PiD - Psychotherapie im Dialog
Related Books
Psychiatry / Psychotherapy / Psychosomatic Medicine
Abstracts (HTML)
List of Authors
A
B
C
D
E
F
G
H
I
K
L
M
N
P
R
S
T
U
V
W
Z
Gehrmann, A.
Antidepressants in pregnancy – focus on therapeutic drug monitoring
Geissler, J.
Serious adverse drug reactions to antipsychotics in children and adolescents with multiple disabilities: Avoidability and potential cost savings by Therapeutic Drug Monitoring
Gerlach, M.
Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting
The therapeutic reference range for olanzapine revised – how to combine old and new findings
Serious adverse drug reactions to antipsychotics in children and adolescents with multiple disabilities: Avoidability and potential cost savings by Therapeutic Drug Monitoring
Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range
Gilles, M.
Ketamine Metabolite Plasma Levels as Potential Blood Markers of Ketamine Efficacy in Treatment Resistant Depression
Grohmann, R.
Current data from the AMSP Project on the risk of treatment with antidepressants and antipsychotics within the clinical setting
Gründer, G
Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factors
Gründer, G.
Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis
How valid are therapeutic reference ranges for psychotropic drugs?
Is it Time to Reevaluate the Therapeutic Reference Range for the Antidepressant Drug Venlafaxine?
Ketamine Metabolite Plasma Levels as Potential Blood Markers of Ketamine Efficacy in Treatment Resistant Depression
The therapeutic reference range for olanzapine revised – how to combine old and new findings
Case series: Higher antipsychotic drug levels in patients with schizophrenia after COVID-19 vaccination
Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range
Grüner, J.
Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis
Güntzel, T.
Serious adverse drug reactions to antipsychotics in children and adolescents with multiple disabilities: Avoidability and potential cost savings by Therapeutic Drug Monitoring